Is Incannex Healthcare Ltd ADR (IXHL) overvalued? · rev $86.0K
Incannex Healthcare Ltd ADR (IXHL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page asks whether Incannex Healthcare Ltd ADR (IXHL) looks expensive on cached numbers — not a short thesis.
Latest reported IXHL revenue for 2025-03-31 was $86.0K. Net income was -$4.0M. IXHL currently screens at market cap $44.3M.
IXHL currently screens at market cap $44.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next IXHL 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the IXHL stock page for the full model, not this heading.
Not investment advice.